扬子江药业集团有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
210
NMPA:210
Drug Approvals
Omega-3-acid ethyl ester 90 Soft Capsules
- Product Name
- ω-3脂肪酸乙酯90软胶囊
- Approval Number
- 国药准字H20249504
- Approval Date
- Dec 1, 2024
NMPA
Diquafosol Sodium Eye Drops
- Product Name
- 地夸磷索钠滴眼液
- Approval Number
- 国药准字H20247253
- Approval Date
- Oct 29, 2024
NMPA
Etomidate Medium and Long Chain Fat Emulsion Injection
- Product Name
- 依托咪酯中/长链脂肪乳注射液
- Approval Number
- 国药准字H20249023
- Approval Date
- Oct 9, 2024
NMPA
Esketamine Hydrochloride Injection
- Product Name
- 盐酸艾司氯胺酮注射液
- Approval Number
- 国药准字H20244027
- Approval Date
- Jun 18, 2024
NMPA
Tegafur, Gimeracil and Oteracil Potassium Capsules
- Product Name
- 替吉奥胶囊
- Approval Number
- 国药准字H20243202
- Approval Date
- Feb 23, 2024
NMPA
Tegafur, Gimeracil and Oteracil Potassium Capsules
- Product Name
- 替吉奥胶囊
- Approval Number
- 国药准字H20243203
- Approval Date
- Feb 23, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 21
- Next
Clinical Trials
No trials found
News
No news found